New hepatitis C regimen shows high cure rates: studies
 

WASHINGTON: An experimental once-daily combination hepatitis C treatment being developed by AbbVie Inc demonstrated very high cure rates across a wide range of disease ge**types, according to data presented on Saturday, likely giving the company a...http://feeds.feedburner.com/~r/com/YEor/~4/S9pN7gkMd6c

أكثر...